Loading...
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation
In patients with chronic lymphocytic leukemia (CLL), persistence of disease after allogeneic stem cell transplantation (alloSCT) can result in poor outcomes. In an effort to improve these outcomes, patients with persistent CLL who were 90–100 days post alloSCT with no evidence of graft-versus-host-d...
Na minha lista:
| Udgivet i: | Biol Blood Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7141702/ https://ncbi.nlm.nih.gov/pubmed/28495642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.04.027 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|